UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients

Cancer science, 2021-04, Vol.112 (4), p.1534-1544

2021

Volltextzugriff (PDF)

Acute eosinophilic pneumonia after changing dosing schedule of nivolumab

Japanese journal of clinical oncology, 2021-12, Vol.51 (12), p.1766-1767

2021

Volltextzugriff (PDF)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy

Internal Medicine, 2021/06/01, Vol.60(11), pp.1743-1746

2021

Volltextzugriff (PDF)

First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis

International journal of clinical oncology, 2021-06, Vol.26 (6), p.1073-1082

2021

Volltextzugriff (PDF)

Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review

Thoracic cancer, 2023-10, Vol.14 (28), p.2886-2889

2023

Volltextzugriff (PDF)

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Journal of clinical medicine, 2022-03, Vol.11 (7), p.1855

2022

Volltextzugriff (PDF)

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

BMC cancer, 2022-09, Vol.22 (1), p.1-966, Article 966

2022

Volltextzugriff (PDF)

Case report: anaplastic lymphoma kinase ( ALK ) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

Frontiers in oncology, 2023-04, Vol.13, p.1110638

2023

Volltextzugriff (PDF)

Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma

The Annals of thoracic surgery, 2015-03, Vol.99 (3), p.975-981

2015

Volltextzugriff (PDF)

Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4292-4301

2020

Volltextzugriff (PDF)

Radiation recall pneumonitis after COVID‐19 vaccination

Thoracic cancer, 2022-01, Vol.13 (1), p.144-145

2022

Volltextzugriff (PDF)

Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.128-134

2021

Volltextzugriff (PDF)

Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010)

Cancer science, 2022-12, Vol.113 (12), p.4327-4338

2022

Volltextzugriff (PDF)

Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody

Cancer Immunology, Immunotherapy, 2021-10, Vol.70 (10), p.2881-2892

2021

Volltextzugriff (PDF)

Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR

BMC pulmonary medicine, 2021-03, Vol.21 (1), p.100-100, Article 100

2021

Volltextzugriff (PDF)

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920904522-1758835920904522

2020

Volltextzugriff (PDF)

Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations

Thoracic cancer, 2022-11, Vol.13 (22), p.3217-3224

2022

Volltextzugriff (PDF)

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

Diagnostics (Basel), 2021-02, Vol.11 (3), p.391

2021

Volltextzugriff (PDF)

Long‐term changes in psoas muscle mass after lobectomy and segmentectomy for early‐stage lung cancer

Journal of cachexia, sarcopenia and muscle, 2023-12, Vol.14 (6), p.2540-2549

2023

Volltextzugriff (PDF)

Randomized phase III study of irinotecan/cisplatin (IP) versus etoposide/cisplatin (EP) for completely resected high-grade neuroendocrine carcinoma (HGNEC) of the lung: JCOG1205/1206

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9006-9006

2020

Volltextzugriff (PDF)

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis

Cancer medicine (Malden, MA), 2024-04, Vol.13 (7), p.e7162-n/a

2024

Volltextzugriff (PDF)

Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells

Laboratory investigation, 2013-10, Vol.93 (10), p.1137-1146

2013

Volltextzugriff (PDF)

Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand‐1 (PD‐L1) expression in surgically resected non‐small cell lung cancer

Thoracic cancer, 2024-06, Vol.15 (17), p.1343-1349

2024

Volltextzugriff (PDF)

Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”

Thoracic cancer, 2024-02, Vol.15 (6), p.458-465

2024

Volltextzugriff (PDF)

1 – 25 von 309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

Englisch
(261)
Japanisch
(108)

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(140)
Humans
(114)
Male
(78)
Oncology
(77)
Female
(75)
Aged
(68)
Middle Aged
(64)
Lung Cancer
(61)
Adult
(47)
Lung Neoplasms - Drug Therapy
(42)
Aged, 80 And Over
(39)
Lung Neoplasms - Pathology
(38)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(31)
Biological And Medical Sciences
(28)
Tumors
(28)
Non-Small Cell Lung Cancer
(27)
Chemotherapy
(26)
Respiratory System
(26)
Medical Sciences
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Haigan. Lung Cancer
(24)
Journal Of Clinical Oncology
(22)
Haigan
(18)
肺癌
(17)
Annals Of Oncology
(16)
Lung Cancer
(13)
Journal Of Thoracic Oncology
(11)
Thoracic Cancer
(10)
European Journal Of Radiology
(9)
Journal Of Experimental Therapeutics & Oncology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients

Acute eosinophilic pneumonia after changing dosing schedule of nivolumab

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy

First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis

Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Case report: anaplastic lymphoma kinase ( ALK ) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma

Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206

Radiation recall pneumonitis after COVID‐19 vaccination

Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery

Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010)

Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody

Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study

Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

Long‐term changes in psoas muscle mass after lobectomy and segmentectomy for early‐stage lung cancer

Randomized phase III study of irinotecan/cisplatin (IP) versus etoposide/cisplatin (EP) for completely resected high-grade neuroendocrine carcinoma (HGNEC) of the lung: JCOG1205/1206

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis

Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells

Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand‐1 (PD‐L1) expression in surgically resected non‐small cell lung cancer

Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”

Suchergebnisse filtern